John F. Crowley - Sep 3, 2021 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Chairman & CEO, Director
Signature
/s/ Christian Formica, Attorney-in-Fact
Stock symbol
FOLD
Transactions as of
Sep 3, 2021
Transactions value $
-$43,381
Form type
4
Date filed
9/8/2021, 06:45 PM
Previous filing
Sep 7, 2021
Next filing
Sep 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Options Exercise $5.43K +1.54K +0.18% $3.53 841K Sep 3, 2021 Direct
transaction FOLD Common Stock Options Exercise $14.1K +3.7K +0.44% $3.82 845K Sep 3, 2021 Direct
transaction FOLD Common Stock Sale -$62.9K -5.24K -0.62% $12.02 840K Sep 3, 2021 Direct F1, F2
holding FOLD Common Stock 64.9K Sep 3, 2021 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Options Exercise $0 -1.54K -100% $0.00* 0 Sep 3, 2021 Common Stock 1.54K $3.53 Direct F3
transaction FOLD Stock Options (right to buy) Options Exercise $0 -3.7K -11.77% $0.00 27.7K Sep 3, 2021 Common Stock 3.7K $3.82 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.00 to $12.08 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 All of these options were fully vested and exercisable as of the transaction date.